pmc-enju-pas Home  

PMC:3312845 / 1153-1611 JSONTXT 21 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T372 7-9 IN denotes in
T373 10-21 JJ denotes endothelial
T374 22-27 NN denotes cells
T375 28-39 VB denotes accompanied
T376 40-42 IN denotes by
T377 43-49 NN denotes SMI-71
T378 50-60 NN denotes expression
T379 61-62 -LRB- denotes (
T380 62-64 DT denotes an
T381 65-76 JJ denotes endothelial
T382 77-84 NN denotes barrier
T383 85-92 NN denotes antigen
T384 92-93 -RRB- denotes )
T385 95-109 NN denotes Neutralization
T386 110-112 IN denotes of
T387 113-118 NN denotes TNF-α
T388 119-121 IN denotes by
T389 122-129 JJ denotes soluble
T390 130-133 NN denotes TNF
T391 134-137 NN denotes p55
T392 138-146 NN denotes receptor
T393 147-148 -LRB- denotes (
T394 148-156 NN denotes sTNFp55R
T395 156-157 -RRB- denotes )
T396 158-166 NN denotes infusion
T397 167-177 VB denotes attenuated
T398 178-188 JJ denotes SE-induced
T399 189-198 JJ denotes vasogenic
T400 199-204 NN denotes edema
T401 205-208 CC denotes and
T402 209-217 JJ denotes neuronal
T403 218-225 NN denotes damages
T404 226-229 IN denotes via
T405 230-240 NN denotes inhibition
T406 241-243 IN denotes of
T407 244-254 NN denotes p65-Thr435
T408 255-270 NN denotes phosphorylation
T409 271-273 IN denotes in
T410 274-285 JJ denotes endothelial
T411 286-291 NN denotes cells
T412 293-304 RB denotes Furthermore
T413 304-305 -COMMA- denotes ,
T414 306-314 NN denotes sTNFp55R
T415 315-323 NN denotes infusion
T416 324-331 VB denotes reduced
T417 332-342 JJ denotes SE-induced
T418 343-353 NN denotes neutrophil
T419 354-366 NN denotes infiltration
T420 367-369 IN denotes in
T421 370-373 DT denotes the
T422 374-376 NN denotes PC
T423 379-389 NN denotes Conclusion
T424 390-395 DT denotes These
T425 396-404 NN denotes findings
T426 405-412 VB denotes suggest
T427 413-417 IN denotes that
T428 418-429 NN denotes impairments
T429 430-432 IN denotes of
T430 433-444 JJ denotes endothelial
T431 445-449 NN denotes cell
R203 T374 T372 arg2Of cells,in
R204 T374 T373 arg1Of cells,endothelial
R205 T374 T375 arg2Of cells,accompanied
R206 T378 T375 arg1Of expression,accompanied
R207 T378 T376 arg2Of expression,by
R208 T378 T377 arg1Of expression,SMI-71
R209 T378 T379 arg1Of expression,(
R210 T383 T379 arg2Of antigen,(
R211 T383 T380 arg1Of antigen,an
R212 T383 T381 arg1Of antigen,endothelial
R213 T383 T382 arg1Of antigen,barrier
R214 T384 T379 arg3Of ),(
R215 T385 T386 arg1Of Neutralization,of
R216 T385 T388 arg1Of Neutralization,by
R217 T385 T397 arg1Of Neutralization,attenuated
R218 T387 T386 arg2Of TNF-α,of
R219 T392 T389 arg1Of receptor,soluble
R220 T392 T390 arg1Of receptor,TNF
R221 T392 T391 arg1Of receptor,p55
R222 T392 T393 arg1Of receptor,(
R223 T394 T393 arg2Of sTNFp55R,(
R224 T395 T393 arg3Of ),(
R225 T396 T388 arg2Of infusion,by
R226 T396 T392 arg1Of infusion,receptor
R227 T397 T404 arg1Of attenuated,via
R228 T399 T400 arg1Of vasogenic,edema
R229 T399 T401 arg1Of vasogenic,and
R230 T402 T401 arg2Of neuronal,and
R231 T403 T397 arg2Of damages,attenuated
R232 T403 T398 arg1Of damages,SE-induced
R233 T403 T399 arg1Of damages,vasogenic
R234 T403 T402 arg1Of damages,neuronal
R235 T405 T404 arg2Of inhibition,via
R236 T405 T406 arg1Of inhibition,of
R237 T408 T406 arg2Of phosphorylation,of
R238 T408 T407 arg1Of phosphorylation,p65-Thr435
R239 T408 T409 arg1Of phosphorylation,in
R240 T411 T409 arg2Of cells,in
R241 T411 T410 arg1Of cells,endothelial
R242 T415 T414 arg1Of infusion,sTNFp55R
R243 T415 T416 arg1Of infusion,reduced
R244 T416 T412 arg1Of reduced,Furthermore
R245 T416 T413 arg1Of reduced,","
R246 T419 T416 arg2Of infiltration,reduced
R247 T419 T417 arg1Of infiltration,SE-induced
R248 T419 T418 arg1Of infiltration,neutrophil
R249 T419 T420 arg1Of infiltration,in
R250 T422 T420 arg2Of PC,in
R251 T422 T421 arg1Of PC,the
R252 T425 T424 arg1Of findings,These
R253 T425 T426 arg1Of findings,suggest
R254 T428 T429 arg1Of impairments,of